AV

Arcot Vijitha

Director Director DIN 02626733
DIN 02626733 First appointment Dec 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Arcot Vijitha

Data last updated:

Arcot Vijitha was a Director at Atisa Life Sciences Private Limited (2010–2025) and Director at Freyar Therapeutics Private Limited (from 2021). The companies operate in Pharma.

DIN 02626733
Primary Designation Director
Industry Pharma
First Appointment 21 Dec 2010
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atisa Life Sciences Private Limited U24233TG2010PTC071785
Director21 Dec 20102010₹13.5 Lakh (FY 2025)Active
Freyar Therapeutics Private Limited U24290TG2021PTC148901
Director22 Feb 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Freyar Therapeutics Private Limited
Atisa Life Sciences Private Limited
Premium access

Shareholding and investment profile for Arcot Vijitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arcot Vijitha

Arcot Vijitha was first appointed on 21 Dec 2010 as Director at Atisa Life Sciences Private Limited. The most recent appointment on record is 22 Feb 2021 at Freyar Therapeutics Private Limited.

Arcot Vijitha held 2 earlier board appointments: Atisa Life Sciences Private Limited (Director, 21 Dec 2010 to 01 Aug 2025); Freyar Therapeutics Private Limited (Director, from 22 Feb 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available